Home Applications 017378 Application 017378
Type NDA
Sponsor BAXTER HLTHCARE Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE INJECTABLE;INJECTION 30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML Yes Yes 002 PLASMA-LYTE A IN PLASTIC CONTAINER MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE INJECTABLE;INJECTION 30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N017378-001 PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE 30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML INJECTABLE / INJECTION RLD, RS, Approved before 1982 N017378-002 PLASMA-LYTE A IN PLASTIC CONTAINER MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE 30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML INJECTABLE / INJECTION AP RLD, RS 1982-11-22
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N017378-002 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 3 of 3 · 88 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-10-28 04:53 UTC 2022-10 N017378-001 PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER 30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML INJECTABLE / INJECTION AP RLD, RS, Approved before 1982 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 N017378-002 PLASMA-LYTE A IN PLASTIC CONTAINER 30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML INJECTABLE / INJECTION AP RLD, RS 1982-11-22 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N017378-001 PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER 30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML INJECTABLE / INJECTION AP RLD, RS, Approved before 1982 e64feba35796…2022-09-29 23:25 UTC 2022-09 N017378-002 PLASMA-LYTE A IN PLASTIC CONTAINER 30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML INJECTABLE / INJECTION AP RLD, RS 1982-11-22 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N017378-001 PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER 30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML INJECTABLE / INJECTION AP RLD, RS, Approved before 1982 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N017378-002 PLASMA-LYTE A IN PLASTIC CONTAINER 30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML INJECTABLE / INJECTION AP RLD, RS 1982-11-22 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N017378-001 PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER 30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML INJECTABLE / INJECTION RLD, RS, Approved before 1982 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N017378-002 PLASMA-LYTE A IN PLASTIC CONTAINER 30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML INJECTABLE / INJECTION AP RLD, RS 1982-11-22 a50c72e98297…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 54 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Plasma-Lyte A SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE Baxter Healthcare Corporation 6ec9e61c-2c26-402f-8604-f446b2e34058 2019-08-05 Warnings, Adverse reactions Exact identifier application applno (NDA): 017378 application number: NDA017378 ndc (product): 0338-0221
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 10 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0338-0179 Plasma-Lyte 148 SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE Baxter Healthcare Corporation NDA Current 0338-0179 Plasma-Lyte 148 SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE Baxter Healthcare Corporation NDA Current 0338-0179 Plasma-Lyte 148 SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE Baxter Healthcare Corporation NDA Current 0338-0179 Plasma-Lyte 148 SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE Baxter Healthcare Corporation NDA Current 0338-0179 Plasma-Lyte 148 SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE Baxter Healthcare Corporation NDA Current 0338-0221 Plasma-Lyte A Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride and Magnesium Chloride Baxter Healthcare Corporation NDA Current 0338-0221 Plasma-Lyte A Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride and Magnesium Chloride Baxter Healthcare Corporation NDA Current 0338-0221 Plasma-Lyte A Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride and Magnesium Chloride Baxter Healthcare Corporation NDA Current 0338-0221 Plasma-Lyte A Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride and Magnesium Chloride Baxter Healthcare Corporation NDA Current 0338-0221 Plasma-Lyte A Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride and Magnesium Chloride Baxter Healthcare Corporation NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 59606 SUPPL 2019-08-07 59588 SUPPL 2019-08-06 33252 SUPPL 2013-09-17 13122 SUPPL 2013-09-13 10979 SUPPL 2009-02-04 13121 SUPPL 2009-01-30 13120 SUPPL 2002-04-03